Acute lymphoblastic leukaemia trials in Canada
30 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleAnti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)
- Where
- Calgary, Edmonton
- Age
- 2 years to 70 years
- People
- 63
- Run by
- University of Alberta
See details and how to joinNCT03938987 - No phaseTaking peopleHIIT in Youth With Congenital Heart Disease (MedBIKE)
- Where
- Edmonton
- Age
- 10 years to 18 years
- People
- 44
- Run by
- University of Alberta
See details and how to joinNCT04575883 - Phase 1Taking peopleStudy of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- Where
- Toronto
- Age
- 18 years and over
- People
- 242 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT04260022 - Phase 1/2Taking peopleCLIC-1901 for the Treatment of Patients With Relapsed/Refractory CD19 Positive Hematologic Malignancies
- Where
- Ottawa, Vancouver, Winnipeg
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Ottawa Hospital Research Institute
See details and how to joinNCT03765177 - No phaseTaking peopleBright Ideas - CIN Feasibility Study
- Where
- Toronto
- Age
- 4 years to 18 years
- People
- 75 worldwide
- Run by
- The Hospital for Sick Children
See details and how to joinNCT04929899